Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Mittal (New Delhi, India), U. Kumar (New Delhi, India), R. Guleria (New Delhi, India), A. Mohan (New Delhi, India), K. Madan (New Delhi, India), A. Bhalla (New Delhi, India), S. Mathur (New Delhi, India). Bronchoalveolar lavage fluid cytokines in the assessment of interstitial lung disease in systemic sclerosis: a prospective study. 1370

Member's Comments

No comment yet.

Related content which might interest you: Bronchoalveolar lavage findings in the pulmonary impairment related to systemic sclerosis Source: Eur Respir J 2002; 20: Suppl. 38, 470s Year: 2002 Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Source: Eur Respir J 2011; 38: 761-769 Year: 2011 Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases? Source: International Congress 2015 – New insights into IIPs Year: 2015 Retrospective assessment of pulmonary sarcoidosis with the aid of bronchoalveolar lavage (BAL) during the past three-year period in a general hospital Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease Source: Eur Respir Rev 2010 19: 237-241 Year: 2010 Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Usefulness of anti-Ro52 antibodies in the BAL of the patients with ILDs. Pilot study Source: International Congress 2016 – ILD pathogenesis Year: 2016 Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 Bronchoalveolar lavage: how can we use it more effectively to define pathology? Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 Autoantibodies are present in the bronchoalveolar lavage but not circulation in patients with fibrotic interstitial lung disease Source: ERJ Open Res, 8 (1) 00481-2021; 10.1183/23120541.00481-2021 Year: 2022 Clinical and immunological parameters in patients with newly diagnosed sarcoidosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Indication of whole lung lavage in pulmonary alveolar proteinosis – Retrospective study Source: International Congress 2015 – IIPs: orphan Year: 2015 Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001 Influence of systemic steroid treatment on bronchoalveolar (BAL) cytological composition and cell cycle in selected interstitial lung diseases Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Bronchoalveolar lavage Source: Eur Respir Mon; 2010: 48: 59–72 Year: 2010 Main features of cytokine profile in serum and bronchoalveolar lavage fluid in patients with recurrent sarcoidosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Bronchoalveolar lavage in children with diffuse lung disease Source: Annual Congress 2008 - The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease Year: 2008 Bronchoalveolar lavage fluid leukotrienes in the pathomechanism of acute inflammatory events in lung transplant recipients Source: International Congress 2016 – Monitoring comorbidities Year: 2016